Share this post on:

Product Name :
SEL-120

Search keywords :
SEL120-34A

drugId :
null

Target Vo:
Cyclin-dependent kinase 8

Target Vo Short Name :
CDK8

Moa_Name:
Cyclin-dependent kinase 8 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ryvu Therapeutics Sa

Active Company_Name :
GCP-Service International West GmbH

Active Indication_Name:
Myelodysplastic Syndromes

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-PKC zeta (T560) Antibody
Phospho-IKB alpha (Ser32) Antibody (YA183)
CARM1 Antibody (YA812): CARM1 Antibody (YA812) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to CARM1 (2B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related